300
Participants
Start Date
July 28, 2018
Primary Completion Date
September 30, 2022
Study Completion Date
June 30, 2023
MultiStem
single intravenous infusion 18-36 hours after stroke
Placebo
single intravenous infusion 18-36 hours after stroke
RECRUITING
Athersys Investigational Site 601, Taipei
RECRUITING
Athersys Investigational Site 106, Pittsburgh
RECRUITING
Athersys Investigational Site 107, Hershey
RECRUITING
Athersys Investigational Site 118, Columbia
RECRUITING
Athersys Investigational Site 103, Augusta
RECRUITING
Athersys Investigational Site 108, Miami
RECRUITING
Athersys Investigational Site 602, Taoyuan
RECRUITING
Athersys Investigational Site 129, Clearwater
RECRUITING
Athersys Investigational Site 115, Chattanooga
RECRUITING
Athersys Investigational Site 111, Jackson
RECRUITING
Athersys Investigational Site 603, Taichung
RECRUITING
Athersys Investigational Site 130, Toledo
RECRUITING
Athersys Investigational Site 104, Cleveland
RECRUITING
Athersys Investigational Site 109, Akron
RECRUITING
Athersys Investigational Site 125, Minneapolis
RECRUITING
Athersys Investigational Site 121, Chicago
RECRUITING
Athersys Investigational Site 119, Kansas City
RECRUITING
Athersys Investigational Site 124, Wichita
RECRUITING
Athersys Investigational Site 101, Houston
RECRUITING
Athersys Investigational Site 105, Houston
RECRUITING
Athersys Investigational Site 110, Salt Lake City
RECRUITING
Athersys Investigational Site 128, Phoenix
RECRUITING
Athersys Investigational Site 122, Palo Alto
RECRUITING
Athersys Investigational Site 127, Sacramento
RECRUITING
Athersys Investigational Site 102, Portland
RECRUITING
Athersys Investigational Site 113, Boston
Lead Sponsor
Collaborators (1)
Medpace, Inc.
INDUSTRY
Healios K.K.
INDUSTRY